Prescription drug benefits

In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. A prescription drug compromise that would lower costs for Medicare recipients has cleared a key hurdle in the Senate, but Republican resistance signals trouble when the legislation goes to the floor. (AP Photo/Elise Amendola, File)
July 25, 2019 - 5:44 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday, but Republican resistance signaled trouble as the legislation faces floor consideration. The Finance Committee...
Read More
July 25, 2019 - 3:10 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday, but Republican resistance signaled trouble as the legislation faces floor consideration. The Finance Committee...
Read More
July 25, 2019 - 2:13 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients has cleared a key hurdle in the Senate, but Republican resistance signals trouble when the legislation goes to the floor. The Finance Committee voted 19-9 to advance the bill Thursday, but it passed...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. Two senior senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs that serve seniors and low-income people. (AP Photo/Elise Amendola)
July 23, 2019 - 7:19 pm
WASHINGTON (AP) — Two veteran senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs serving seniors and low-income people. Iowa Republican...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. Two senior senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs that serve seniors and low-income people. (AP Photo/Elise Amendola)
July 23, 2019 - 5:50 pm
WASHINGTON (AP) — Two senior senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs serving seniors and low-income people. Iowa Republican...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. Two senior senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs that serve seniors and low-income people. (AP Photo/Elise Amendola)
July 23, 2019 - 11:46 am
WASHINGTON (AP) — Two senior senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs that serve seniors and low-income people. Iowa...
Read More
July 23, 2019 - 10:27 am
WASHINGTON (AP) — Two senior senators — one Republican, one Democrat — are unveiling compromise legislation to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs. Staffers for Iowa Republican Charles Grassley and Oregon...
Read More
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 3:44 pm
WASHINGTON (AP) — After two setbacks this week, President Donald Trump is now focusing his drive to curb drug costs on congressional efforts aimed at helping people on Medicare and younger generations covered by workplace plans. The White House on Thursday yanked its own regulation to ease the...
Read More
In this April 8, 2019, photo Chuck Pope, left, and wife Nina talk about his ongoing battle with rheumatoid arthritis and trying to afford medications to alleviate the condition while at their home in Derry, Pa. Pope had been battling the disease with an injected drug that his insurance covered while he was still working. It relieves pain and stops irreversible joint damage but retails for over $5,000 a month. Now his Medicare plan doesn't cover that drug, and Pope says his condition is deteriorating without it. Meanwhile, sales of approved, cheaper versions have been blocked. (AP Photo/Keith Srakocic)
June 27, 2019 - 10:46 am
TRENTON, N.J. (AP) — They were the drugs that were supposed to save the U.S. tens of billions of dollars. Called "biosimilars," they are near-copies of complex and expensive biologic drugs to treat cancer, rare diseases and autoimmune disorders like rheumatoid arthritis and colitis. But U.S. sales...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 2:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More

Pages